In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
In this 35-minute podcast, Dr. Kaple discusses how the CardioMEMS™ HF System has become an essential tool in managing patients with chronic heart failure.
EP Lab Digest highlights Tampa General Hospital’s NeuroCardiac Program, a unique, collaborative approach to patient care that is shaping the future of heart-brain health.
EP Lab Digest highlights Tampa General Hospital’s NeuroCardiac Program, a unique, collaborative approach to patient care that is shaping the future of heart-brain health.
The JIC Podcast is the official podcast of the Journal of Invasive Cardiology. The Journal of Invasive Cardiology (JIC) is a peer-reviewed scientific medical journal serving clinicians who treat cardiovascular disease.
The JIC Podcast is the official podcast of the Journal of Invasive Cardiology. The Journal of Invasive Cardiology (JIC) is a peer-reviewed scientific medical journal serving clinicians who treat cardiovascular disease.
Dee Dee Wang, MD; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
In this interview, Drs Bhatt and Wang discuss the Door-To-Unload (DTU)-STEMI pilot trial, set up to evaluate the safety and feasibility of LV unloading and delayed reperfusion in patients with STEMI.
In this interview, Drs Bhatt and Wang discuss the Door-To-Unload (DTU)-STEMI pilot trial, set up to evaluate the safety and feasibility of LV unloading and delayed reperfusion in patients with STEMI.
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Emmanouil Brilakis discusses the largest meta-analysis to date investigating the impact of CTO-PCI on clinical events during long-term follow-up. The analysis (Simsek et al), included 58 publications containing a total of 45,527 who underwent...
Emmanouil Brilakis discusses the largest meta-analysis to date investigating the impact of CTO-PCI on clinical events during long-term follow-up. The analysis (Simsek et al), included 58 publications containing a total of 45,527 who underwent...
Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI; Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI
Deepak Bhatt, MD, MPH, Editor-in-Chief of the Journal of Invasive Cardiology (JIC), and Emmanouil Brilakis discuss coronary perforation, a rare but potentially life-threatening complication of PCI.
Deepak Bhatt, MD, MPH, Editor-in-Chief of the Journal of Invasive Cardiology (JIC), and Emmanouil Brilakis discuss coronary perforation, a rare but potentially life-threatening complication of PCI.
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
At the American College of Cardiology (ACC) 2026 Scientific Session, Boston Scientific presented results from two late-breaking randomized controlled trials evaluating device-based approaches in cardiovascular care: CHAMPION-AF, studying the...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
With FDA clearance and CE marking, IntraSight Plus...
Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient care
With FDA clearance and CE marking, IntraSight Plus...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
New Britain, PA, March 16, 2026 – Thrombolex, Inc., a commercial-stage medical device company advancing a differentiated pharmaco-mechanical lysis (PML) platform for the treatment of pulmonary embolism (PE) and other thromboembolic diseases,...
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
The study found that AK-AVS can detect aortic stenosis through routine ECGs up to 4.5 years before TAVR intervention, potentially enabling earlier detection, easier-to-access monitoring, and better timing of intervention.
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Salus Scientific and Tallahassee Memorial HealthCare (TMH) announced the successful implementation and first clinical use of AeroShield™, a groundbreaking radiation protection technology developed by Salus Scientific.
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
Sunnyvale, California – Avantec Vascular, a NIPRO Company, has received FDA 510(k) clearance for a thrombectomy system that will enable a new type of treatment for patients with thrombus in the peripheral venous...
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
New York, NY – Mount Sinai researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk...
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
The HOTWIRE™ Transseptal Access System combines a novel RF guidewire with a next-generation RF generator designed to optimize transseptal access, streamline procedural workflows and improve patient outcomes with the best-in-class platform for...
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
Penumbra recently launched the Lightning Flash® 3.0 Computer Assisted Vacuum Thrombectomy (CAVT™) system, which includes significant upgrades that further advance our leading venous thromboembolism (VTE) platform.
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
“In appropriately selected patients who survived a heart attack and do not have heart failure or left ventricular systolic dysfunction, routine continuation of beta-blockers indefinitely may not be necessary,” said Joo-Yong Hahn, MD.
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
The study followed nearly 12,000 adults for approximately 16 years. Investigators applied AI to participants' standard coronary artery calcium scans to measure fat surrounding the heart.
At his CRT 2026 session, Matthew Beckwith of the FDA outlined updated guidance on real-world evidence and introduced Predetermined Change Control Plans for artificial intelligence AI-enabled medical devices.
At his CRT 2026 session, Matthew Beckwith of the FDA outlined updated guidance on real-world evidence and introduced Predetermined Change Control Plans for artificial intelligence AI-enabled medical devices.
At his CRT 2026 Keynote Lecture, Dr James L. Cox emphasized the importance of treating atrial fibrillation during cardiac surgery, underscoring that failure to do so significantly worsens long-term outcomes.
At his CRT 2026 Keynote Lecture, Dr James L. Cox emphasized the importance of treating atrial fibrillation during cardiac surgery, underscoring that failure to do so significantly worsens long-term outcomes.
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
Treatment with enlicitide resulted in statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol (LDL-C) compared to bempedoic acid, ezetimibe or bempedoic acid with ezetimibe at eight weeks (day 56)...
Dr Apurva Patel discusses insights from the study, “Tailored Solutions for Structural Valve Degeneration: Valve-in-Valve-in-Valve TAVR With Coronary Leaflet Modification and Balloon Valve Fracture,” presented at the 2026 ACC Scientific...
Dr Apurva Patel discusses insights from the study, “Tailored Solutions for Structural Valve Degeneration: Valve-in-Valve-in-Valve TAVR With Coronary Leaflet Modification and Balloon Valve Fracture,” presented at the 2026 ACC Scientific...
Dr Saad Ur Rahman discusses findings from “National Trends in Aortic Stenosis Mortality in the Pre- and Post-TAVR Eras in the United States 1999–2023,” presented at the 2026 ACC Scientific Sessions.
Dr Saad Ur Rahman discusses findings from “National Trends in Aortic Stenosis Mortality in the Pre- and Post-TAVR Eras in the United States 1999–2023,” presented at the 2026 ACC Scientific Sessions.
Dr Devi Nair's session at CRT 2026 reviewed the rapidly evolving landscape of next-generation left atrial appendage closure devices for stroke prevention in atrial fibrillation, emphasizing iterative improvements in plug and plication...
Dr Devi Nair's session at CRT 2026 reviewed the rapidly evolving landscape of next-generation left atrial appendage closure devices for stroke prevention in atrial fibrillation, emphasizing iterative improvements in plug and plication...
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
The study utilized Tempus Next, an AI platform that identifies significant AS or MR patients who may meet guideline-indicated therapy criteria, but do not have a treatment plan in place.
